As of March 23, 2026, Anika Therapeutics's top three insider holders are Cheryl R Blanchard (Director, 211.45K shares), David Colleran (Evp, General Counsel, Corp Sec, 53.10K shares), Glenn R. Larsen (Director, 50.26K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Cheryl R Blanchard | 258,788 | 0 | 17 Mar, 2026 | |
| David Colleran | Evp, General Counsel, Corp Sec | 67,570 | 0 | 17 Mar, 2026 |
| Glenn R. Larsen | 50,258 | 0 | 24 Jun, 2025 | |
| Susan L N Vogt | 50,213 | 0 | 24 Jun, 2025 | |
| John B Iii Henneman | 49,871 | 0 | 24 Jun, 2025 | |
| Stephen Richard | 47,871 | 0 | 24 Jun, 2025 | |
| Michael L Levitz | Evp, Cfo, Treasurer | 46,955 | 0 | 12 Mar, 2024 |
| Sheryl L Conley | 42,568 | 0 | 24 Jun, 2025 | |
| Gary P Fischetti | 41,613 | 0 | 24 Jun, 2025 | |
| Jeffery S Thompson | 31,575 | 0 | 16 Jun, 2023 | |
| Thomas Finnerty | Evp, Human Resources | 24,598 | 0 | 11 Mar, 2022 |
| Ian Mcleod | Svp, Cao Treasurer | 24,107 | 0 | 17 Mar, 2026 |
| Stephen D. Griffin | President And Ceo | 23,963 | 0 | 17 Mar, 2026 |
| Anne Nunes | Svp, Chief Operations Officer | 20,654 | 0 | 18 Mar, 2025 |
| William R Jellison | 20,403 | 0 | 24 Jun, 2025 | |
| Joseph H Capper | 20,403 | 0 | 24 Jun, 2025 | |
| Raymond J Land | 12,125 | 0 | 21 Jun, 2021 | |
| James Loerop | Evp Business Development | 5,592 | 0 | 12 Jul, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 19 Mar, 2026 | Ian Mcleod | Restricted Stock Unit | A | 13,097 | $0.00 | 13,097 | D | A |
| 19 Mar, 2026 | Ian Mcleod | Restricted Stock Unit | A | 11,194 | $0.00 | 11,194 | D | A |
| 19 Mar, 2026 | Ian Mcleod | Premium Priced Stock Appreciation Rights | A | 17,663 | $0.00 | 17,663 | D | A |
| 14 Mar, 2026 | Ian Mcleod | Common Stock | A | 3,774 | - | 22,518 | D | M |
| 14 Mar, 2026 | Cheryl R Blanchard | Common Stock | A | 24,519 | - | 235,969 | D | M |
| 14 Mar, 2026 | David Colleran | Common Stock | A | 9,388 | - | 62,488 | D | M |
| 14 Mar, 2026 | Stephen D. Griffin | Common Stock | A | 12,824 | - | 23,495 | D | M |
| 14 Mar, 2026 | Stephen D. Griffin | Common Stock | A | 6,412 | $0.00 | 29,907 | D | A |
| 14 Mar, 2026 | Cheryl R Blanchard | Common Stock | A | 24,520 | $0.00 | 260,489 | D | A |
| 14 Mar, 2026 | David Colleran | Common Stock | A | 4,694 | $0.00 | 67,182 | D | A |
| 14 Mar, 2026 | Ian Mcleod | Common Stock | A | 1,161 | $0.00 | 23,679 | D | A |
| 14 Mar, 2026 | David Colleran | Common Stock | D | 4,168 | $14.20 | 63,014 | D | F |
| 14 Mar, 2026 | Cheryl R Blanchard | Common Stock | D | 14,728 | $14.20 | 245,761 | D | F |
| 14 Mar, 2026 | Stephen D. Griffin | Common Stock | D | 5,944 | $14.20 | 23,963 | D | F |
| 14 Mar, 2026 | Ian Mcleod | Common Stock | D | 1,449 | $14.20 | 22,230 | D | F |
| 15 Mar, 2026 | Cheryl R Blanchard | Common Stock | A | 25,131 | - | 270,892 | D | M |
| 14 Mar, 2026 | Stephen D. Griffin | Restricted Stock Unit | D | 12,824 | $0.00 | 25,649 | D | M |
| 15 Mar, 2026 | David Colleran | Common Stock | A | 6,449 | - | 69,463 | D | M |
| 15 Mar, 2026 | Ian Mcleod | Common Stock | A | 2,658 | - | 24,888 | D | M |
| 15 Mar, 2026 | Ian Mcleod | Common Stock | D | 781 | $14.20 | 24,107 | D | F |